← Leaderboards
Krishnansu Sujata Tewari
University Of California-Irvine
$553,978
Attributed
$733,315
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $185.8K · FY2011–20$200K$150K$100K$50K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$733,315 · 2
By mechanism
P30$374,641 · 1
R21$358,674 · 1
Top collaborators
- John P Fruehauf2 shared
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsTumorWomanProtocols DocumentationMalignant NeoplasmsAreaMinorityMonitorFamilyEnsureLaboratoriesCancer CenterCancer Center Support GrantCancer Clinical TrialInstitutionConflict (Psychology)Comprehensive Cancer CenterData ManagementDiscipline Of NursingDrug IndustryEquilibriumChargeClinicDesign
Grant awards (7)
Protocol Review and Monitoring System (PRMS)$83,908
P30 · FY2020 · CA · contact PI
Protocol Review and Monitoring System (PRMS)$83,911
P30 · FY2019 · CA · contact PI
Protocol Review and Monitoring System (PRMS)$83,916
P30 · FY2018 · CA · contact PI
Protocol Review and Monitoring System (PRMS)$48,202
P30 · FY2017 · CA · contact PI
Protocol Review and Monitoring System (PRMS)$74,704
P30 · FY2016 · CA · contact PI
Novel biologic markers of treatment resistance in locally advanced cervical carci$172,916
R21 · FY2012 · CA · contact PI
Novel biologic markers of treatment resistance in locally advanced cervical carci$185,758
R21 · FY2011 · CA · contact PI